Clinical Director and Chairman of the Interdisciplinary Breast Unit Clinics of Essen-Mitte in Germany, where he is also Lead of the Breast Cancer Research Program. He is also Executive Board Member of AGO and a Scientific Director of the WSG, an academic study group for breast cancer. 

Prof. Sherko Kümmel has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Novartis, Roche Pharma, Pfizer, Lilly, Amgen, MSD, Exact Science, Agendia, AstraZeneca, Daiichi Sankyo, Somatex, Hologic, Sonoscape, Gilead, Seagen, Menarini Stemline and PINK.